Accuray Incorporated carries a market capitalization of 43.97M, placing it among publicly traded companies globally. Its enterprise value stands at 190.02M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 43.97M |
| Enterprise Value | 190.02M |
Accuray Incorporated currently has 118.93M shares outstanding.
| Shares Outstanding | 118.93M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.11, and the price-to-book ratio stands at -0.08.
| PE Ratio | N/A |
| PS Ratio | 0.11 |
| PB Ratio | -0.08 |
| P/TBV Ratio | -2.82 |
| P/FCF Ratio | -3.70 |
| P/OCF Ratio | -2.39 |
On an enterprise value basis, Accuray Incorporated trades at an EV/EBITDA multiple of 81.37 and an EV/FCF ratio of 10.77. The EV/Sales ratio of 0.44 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 33.82 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.44 |
| EV / EBITDA | 81.37 |
| EV / EBIT | 33.82 |
| EV / FCF | 10.77 |
Accuray Incorporated maintains a current ratio of 1.42, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 437.33, indicating elevated leverage, while an interest coverage ratio of -0.27 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.42 |
| Quick Ratio | 0.58 |
| Debt / Equity | 437.33 |
| Debt / EBITDA | -23.99 |
| Interest Coverage | -0.27 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -9.90 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -3.49 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.07 |
Over the trailing twelve months, Accuray Incorporated has paid 2.46M in income taxes, reflecting an effective tax rate of 45.77.
| Income Tax | 2.46M |
| Effective Tax Rate | 45.77 |
Accuray Incorporated's stock has declined approximately -76.75472% over the past 52 weeks. The 50-day moving average sits at 0.39, while the 200-day moving average is 0.93.
| Beta (5Y) | N/A |
| 52-Week Price Change | -76.75472% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.93 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Accuray Incorporated generated 428.57M in revenue and converted that into -46.13M in net income, yielding earnings per share of -0.39. EBITDA reached -7.60M, while operating income came in at -15.12M.
| Revenue | 428.57M |
| Gross Profit | 114.89M |
| Operating Income | -15.12M |
| Pretax Income | -43.67M |
| Net Income | -46.13M |
| EBITDA | -7.60M |
| EBIT | -15.12M |
| Earnings Per Share (EPS) | -0.39 |
Accuray Incorporated holds 38.07M in cash and equivalents against 182.40M in total debt, resulting in a net debt position of 107.11M. Total book value stands at -566.41M, with working capital of 87.37M providing operational flexibility.
| Cash & Cash Equivalents | 38.07M |
| Total Debt | 182.40M |
| Net Debt | 107.11M |
| Equity (Book Value) | -566.41M |
| Book Value Per Share | -4.81 |
| Working Capital | 87.37M |
Accuray Incorporated produced -19.12M in operating cash flow over the past twelve months. After subtracting -6.72M in capital expenditures, free cash flow totaled -25.84M - equivalent to -0.22 per share.
| Operating Cash Flow | -19.12M |
| Capital Expenditures | -6.72M |
| Free Cash Flow | -25.84M |
| FCF Per Share | -0.22 |
Accuray Incorporated operates with a gross margin of 26.81, reflecting its pricing power and cost economics. The operating margin of -3.53 and net profit margin of -10.76 provide insight into operational efficiency.
| Gross Margin | 26.81 |
| Operating Margin | -3.53 |
| Pretax Margin | -10.19 |
| Profit Margin | -10.76 |
| EBITDA Margin | -1.77 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 5.45 |
| FCF Yield | -27.00 |
Accuray Incorporated posts an Altman Z-Score of -0.73, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.73 |